Keymed Biosciences Inc. (2162.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.15B |
| Enterprise Value | 13.4B |
| P/E Ratio | 21.71 |
| PEG Ratio | -0.81 |
| Price/Sales Ratio | 20.71 |
| Price/Book Ratio | 4.27 |
| Enterprise/Revenue | 18.69 |
| Enterprise/EBITDA | -29.41 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.93 |
| Operating Margin | -0.75 |
AD
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.23 |
Income Statement
| Revenue | 697.77M |
| Revenue/Share | 2.9 |
| Gross Profit | 516.51M |
| EBITDA | -486.83M |
| Net Income | -509.11M |
| Diluted EPS | -1.86 |
Balance Sheet
| Total Cash | 3.24B |
| Total Cash/Share | 11.43 |
| Total Debt | 696.57M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 4.83 |
| Book Value Per Share | 14.13 |
Price History
| 52-Week Change | 20.14 |
| 52-Week High | 89.75 |
| 52-Week Low | 44.66 |
| Moving Average 50 Days | 75.63 |
| Moving Average 200 Days | 69.23 |
Statistics
| Average Volume | 2.2M |
| Shares Outstanding | 282.11M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
